Issue Archive
October 2020 | Volume 19 | Issue 10
Original Articles
Prospective Analysis in Patients With HAE Under Prophylaxis With Lanadelumab: A Real-life Experience
Background and Objectives: Patients with the rare disease hereditary angioedema (HAE) suffer from recurrent acute attacks of edema. There is no curative therapy, but the frequency of attacks and quali...
Read MoreHyaluronidase in Dermatology: Uses Beyond Hyaluronic Acid Fillers
Hyaluronidase is mostly widely recognized for its off-label use in correction of complications of hyaluronic acid fillers. However, its utility in other aspects of dermatology is less widely acknowled...
Read MoreClinical Relevance of Skin Pain in Atopic Dermatitis
Skin pain is increasingly recognized as an impactful symptom in atopic dermatitis (AD) because of its association with patient discomfort, disease burden, and reduced quality of life. Although the nat...
Read MoreDevelopment and Evaluation of an Atopic Dermatitis Care Plan for Providers
Background/Significance of problem: Atopic Dermatitis (AD) is a common, chronic, inflammatory dermatosis and skin disease that follows a relapsing pattern and requires a dynamic stepwise approach to m...
Read MoreHydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results
Background: No FDA-approved prescription therapies are available for common warts.
Objective: We evaluated a proprietary hydrogen peroxide topical solution, 45% (w/w) (HP45) for treatment ...
Read MoreTopical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis
Mild to moderate atopic dermatitis (AD) occurs frequently in children and adults and is usually managed through the use of pharmacologic treatments, such as topical corticosteroids (TCS) and topical c...
Read MoreImpact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study
Background: Atopic dermatitis (AD) has a negative impact on patients’ quality of life (QoL).
Objective: To report the impact of specific AD lesion locations on QoL in adult patients with A...
Read MoreTransient Acantholytic Dermatosis (Grover Disease) Associated With Chemotherapy: Review of Potential Pathophysiology, Current Treatments and Future Directions for Treatment
Introduction: Transient acantholytic dermatosis has been frequently reported in patients with malignancies. While paraneoplastic cases have been reported, most eruptions occur in the setting of chemot...
Read MoreIncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Background: Recently reported clinical data provides evidence that increasing the dose of botulinum toxin A increases the duration of efficacy. A 2-stage Phase 2, randomized, double-blind study invest...
Read MoreOutcome Disparities Among Men and Women With COVID-19: An Analysis of the New York City Population Cohort
Background: Growing evidence suggests a possible sex disparity in COVID-19 disease related outcomes.
Objective: To explore the sex disparity in COVID-19 cases and outcomes using New York City (N...
Read MoreRationale for Use of Combination Therapy in Rosacea
Background: Rosacea is a chronic skin condition characterized by primary and secondary manifestations affecting the centrofacial skin. The primary diagnostic phenotypes for rosacea are fixed centrofac...
Read MoreAtopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance Options
Background: Atopic dermatitis (AD) is a common skin condition characterized by disturbed barrier function, skin inflammation, and cutaneous dysbiosis. Clinically, it manifests as chronic-recurrent xer...
Read More
Case Reports
Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion: Case Report
Skin of color patients with psoriasis face unique challenges related to disease characteristics and treatment. Dyspigmentation, including postinflammatory hypo- and hyperpigmentation, more frequently ...
Read MorePersistent Agminated CD30+ Lymphoproliferative Disorder
Supplements
FULL SUPPLEMENT: The Biological Impact of Oats: Eczema and Beyond
The objective of this Supplement is to highlight the data supporting the use of colloidal oatmeal in the treatment of atopic dermatitis and other skin conditions resulting from an impaired skin barrie...
Read MoreARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis
Colloidal oatmeal has a long-standing history in the treatment of dermatologic disease. It is composed of various phytochemicals, which contribute to its wide-ranging function and clinical use. It has...
Read MoreARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema
Colloidal oatmeal has a diverse array of applications, clinical benefits, and uses beyond atopic dermatitis. First and foremost, it has been shown to be of benefit in the treatment of atopic dermatiti...
Read More
